QUALITY IMPROVEMENT CASE STUDY
From Medication Discrepancies to Safety
Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) often manage complex medication regimens across multiple prescribers and care settings. Without consistent medication reconciliation, these patients face an elevated risk of medication discrepancies, adverse drug events, treatment complications, and avoidable healthcare utilization.
This quality-improvement case study examines how PharmD Live integrated a virtual, clinical pharmacist-led medication reconciliation service into a Chronic Care Management program at a multisite nephrology practice. It explores how clinical pharmacists worked alongside the nephrology care team to identify medication-related risks, improve medication-list accuracy, and strengthen care for Medicare beneficiaries with CKD and ESRD.
The findings reveal the scale of medication discrepancies within this high-risk population and demonstrate the potential clinical, financial, and patient-experience value of embedding clinical pharmacist expertise into nephrology care.
Download the case study to discover:
- The prevalence and types of medication discrepancies identified among Medicare patients
- How pharmacist-led medication reconciliation was incorporated into nephrology workflows
- The program’s impact on medication safety and patient experience
- The estimated cost avoidance associated with clinical pharmacist interventions
- Practical considerations for reducing medication-related risk across CKD and ESRD populations